Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
ORIX
IX
$44.1B
| $1.31M | ﹤0.01% |
70,330
+16,890
| +32% | +$307K |
|
2752
Miller Industries
MLR
$643M
| $1.31M | ﹤0.01% |
30,950
| – | – |
|
2753
Butterfly Network
BFLY
$2.52B
| $1.3M | ﹤0.01% |
1,208,016
+95,185
| +9% | +$94.2K |
|
2754
Zymeworks
ZYME
$1.77B
| $1.3M | ﹤0.01% |
125,491
+3,625
| +3% | +$28.9K |
|
2755
Amalgamated Financial
AMAL
$1.52B
| $1.3M | ﹤0.01% |
48,384
-1,100
| -2% | -$22.6K |
|
|
ICVX
2756
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $1.3M | ﹤0.01% |
82,642
+10,783
| +15% | +$104K |
|
2757
Vaalco Energy
EGY
$602M
| $1.3M | ﹤0.01% |
290,069
-6,014
| -2% | -$26.4K |
|
|
TBRG
2758
DELISTED
TruBridge
TBRG
| $1.28M | ﹤0.01% |
114,284
+1,260
| +1% | +$16K |
|
2759
CNB Financial Corp
CCNE
$1.03B
| $1.27M | ﹤0.01% |
56,418
| – | – |
|
2760
Harvard Bioscience
HBIO
$27.8M
| $1.27M | ﹤0.01% |
23,668
| – | – |
|
2761
Astronics
ATRO
$4.34B
| $1.26M | ﹤0.01% |
86,768
| – | – |
|
2762
Nature's Sunshine
NATR
$273M
| $1.26M | ﹤0.01% |
72,760
+48
| +0.1% | +$829 |
|
|
SNPO
2763
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $1.25M | ﹤0.01% |
140,704
-1,845
| -1% | -$15K |
|
2764
Olema Pharmaceuticals
OLMA
$913M
| $1.25M | ﹤0.01% |
89,210
+9,258
| +12% | +$124K |
|
2765
ENI
E
$79.7B
| $1.25M | ﹤0.01% |
36,763
+12,680
| +53% | +$412K |
|
2766
Daktronics
DAKT
$997M
| $1.24M | ﹤0.01% |
146,793
+41,583
| +40% | +$397K |
|
2767
Getty Images
GETY
$124M
| $1.24M | ﹤0.01% |
236,908
+19,311
| +9% | +$96.9K |
|
2768
Tiptree Inc
TIPT
$668M
| $1.23M | ﹤0.01% |
64,674
-1,465
| -2% | -$25.4K |
|
2769
Traeger
COOK
$172M
| $1.22M | ﹤0.01% |
8,967
+195
| +2% | +$25.2K |
|
2770
Evolus
EOLS
$536M
| $1.21M | ﹤0.01% |
114,779
+173
| +0.2% | +$1.55K |
|
2771
Daily Journal
DJCO
$767M
| $1.21M | ﹤0.01% |
3,539
| – | – |
|
2772
IBEX
IBEX
$470M
| $1.2M | ﹤0.01% |
63,198
-3,440
| -5% | -$59.8K |
|
2773
Invivyd
IVVD
$216M
| $1.2M | ﹤0.01% |
303,915
+36,435
| +14% | +$68.9K |
|
2774
Utah Medical Products
UTMD
$230M
| $1.19M | ﹤0.01% |
14,172
-330
| -2% | -$27.4K |
|
2775
GrowGeneration
GRWG
$107M
| $1.19M | ﹤0.01% |
474,166
+50,302
| +12% | +$123K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.